Guangdong Hengrui Pharmaceutical Co., Ltd

This study tested a single injection of a new drug called SHR-1905 in 9 teenagers with asthma. The goal was to see how the drug moves through the body, if it is safe, and whether it helps control asthma. Participants were aged 12 to 17 and had asthma for at least 6 months. The st…

This early-stage study tested a new drug called SHR-2173 in 30 adults with systemic lupus erythematosus (SLE). The main goal was to see if multiple injections under the skin are safe and how the drug moves through the body. Participants received the drug and were monitored for si…

This early-stage study tested a new drug called SHR-1139 in 64 people. First, healthy volunteers received a single shot or IV dose to check safety. Then, patients with moderate-to-severe plaque psoriasis got multiple shots. The main goal was to see if the drug is safe and how the…

This early-stage study tested a new inhaled drug called SHR-4597 in 62 people: healthy volunteers and patients with mild to severe asthma. The main goal was to see if the inhaler is safe and tolerable. Researchers gave single or multiple doses and watched for side effects. This i…

This study tested an experimental drug called HRS-2261 in 97 adults with refractory chronic cough (a cough lasting over a year that doesn't respond to usual treatments). Participants took the drug or a placebo for 4 weeks. Researchers measured changes in cough severity and qualit…